Home/Syna Therapeutics/Dr. Andreu Soldevila
DA

Dr. Andreu Soldevila

Co-founder & CEO

Syna Therapeutics

Therapeutic Areas

Syna Therapeutics Pipeline

DrugIndicationPhase
LB-0702Hematology pathologiesPre-clinical